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The oxidative derivatization method using diperoxyazelaic acid for the indirect spectrophotometric 
determination of Perphenazine dihydrochloride is presented. Diperoxyazelaic acid is introduced as a 
derivatizing agent for Perphenazine, yielding sulfoxides. This reaction product was successfully 
employed for the spectrophotometric determination of Perphenazine dihydrochloride. The UV 
spectroscopic detection of sulfoxide has been proven to be the more robust and selective. The 
method developed allowed determination of Perphenazine dihydrochloride in the concentration 
range of 1–40 µg/mL. The limits of quantification (LOQ=10S) is 3.3 µg·ml-1. A new 
spectrophotometric method has been developed, and the possibility of the quantitative 
determination of Perphenazine dihydrochloride in Perphenazine Tablets has been demonstrated. 
The present method is precise, accurate and other inactive excipients of the drug do not interfere. 
RSD = 2.00%; δ=(  -µ) 100%/µ = – 0.85 %). 
________________________________________________________________________________ 
Introduction 
Perphenazine (PER), 2-[4-[3-(2- 
chlorophenothiazin- 10- yl) propyl] piperazin- 
1- yl] ethanol, chemically belongs to the 
piperazinyl phenothiazine family of drugs with 
the chemical formula – C21H26CIN3OS (Fig. 1). 
Because of its neuroleptic and antidepressive 
effects it is often prescribed for the treatment of 
mental illnesses, such as schizophrenia and 
schizoaffective psychosis in order to decrease 
restlessness, aggressiveness and impulsive 
behavior. It is also found to be effective in the 
treatment of Parkinson's disease [1]. It is 
available as oral tablets containing 2 mg, 4 mg, 
8 mg, and 16 mg of perphenazine. 
 
Figure 1. The chemical formula of Perphenazine base 
(syn. Etaperazine) 
Perphenazine hydrochloride, as well as other 
2,10-substituted phenothiazine derivatives, 
possesses some interesting chemical properties. 
It is very susceptible to oxidation by many 
oxidizing agents, such as H2O2, Cr2O72-, VO3-, 
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Ce4+, Fe3+, [Fe(CN)6]3-, Au3+, chloramine T, etc. 
[2]. The oxidation reaction of Perphenazine 
proceeds in two steps. The ﬁrst step is the loss 
of one electron giving a violet semiquinone free 
radical cation. In the second step of reaction, the 
free radical cation loses another electron giving 
the colorless Perphenazine sulfoxide (Ph-SO). 
The described process can be presented as 
follows (see Scheme in Figure 2.) [3]. 
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Figure 2. The scheme of Phenothiazine derivatives 
oxidation 
Thus, the final oxidation product is 
Phenothiazine S-oxide. The monitoring of 
Perphenazine is important for quality assurance 
in pharmaceutical industry and for obtaining the 
optimum therapeutic concentrations in the body 
fluids to minimize the risk of toxicity. 
Therefore, it is important to develop simple and 
sensitive methods for the determination of this 
drug. A wide variety of analytical procedures 
are available for the determination of 
perphenazine in pharmaceutical preparations 
and biological samples, such as HPLC [4,5], 
mass spectrometry [6], spectrophotometry [7,8], 
electrochemistry [9-11], electrophoresis [12] 
fluorescence [13] and chemiluminescence [14]. 
 The official method for the assay of 
Perphenazine in tablets described by the British 
Pharmacopoeia (BPh) [15] is a 
spectrophotometric method, in which the 
ultraviolet absorption spectra of the second 
derivative of the following solutions are 
recorded in the range from 210 to 290 nm, and 
the amplitude is measured from the peak at 265 
nm to the trough at 255 nm. The C21H26N3OS 
content was calculated using the declared 
C21H26N3OS content in BPCRS perphenazine. 
In return, for the assay of perphenazine 
injection, syrup and tablets Perphenazine the 
United States Pharmacopoeia (USP) [16] 
recommends applying the procedure with the 
acid-alcohol solution and Palladium chloride 
solution with the subsequent measurement of 
the optical density at a wavelength of about 480 
nm. The content is found by the standard 
method. One of the promising areas in 
improving the selectivity and sensitivity of the 
determination of phenothiazine derivatives is an 
approach based on their determination in the 
form of a functional derivative - S-oxidation 
product produced from the analytical reagent 
using a peroxide derivative of organic acid. 
Chemical conversion covers only the functional 
group of the active substance molecules, and 
therefore, the selectivity of the active substance 
determination is achieved [17,18]. 
 We have offered to perform the 
Perphenazine assay by using indirect 
spectrophotometry in the form of the 
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corresponding sulfoxide produced with 
diperoxyazelaic acid as an analytical oxidizing 
reagent.   
The scheme of Perphenazine oxidation 
with diperoxy azelaic acid in the acidic medium 
is given in Figure 3. 
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Figure 3. The scheme of Perphenazine oxidation with 
diperoxy azelaic acid in the acidic medium. 
 
Experimental part 
Material and methods  
Reagents  
Diperoxyazelaic acid. Diperoxyazelaic 
acid was prepared by acylation of hydrogen 
peroxide with azelaic acid in the concentrated 
sulfuric acid according to the Swern method 
[18].  
Potassium iodide solution. Dissolve 10 g 
of potassium iodide in fresh boiled and cooled 
water, and dilute the solution to the volume of 
100 mL. The solution should be colorless.  
0.1 mol L-1 sodium thiosulfate standard 
solution was prepared using the titer fixanal 
ampoule. 
The hydrochloric acid solutions: c(НСl) 
=2 mol L-1; 0.4 mol L-1 and 0.2 mol L-1.  
The determination of Perphenazine was 
made using commercial tablets available in 
Russia: “Ethaperazine” (Perphenazine) film-
coated tablets, 10 mg, No. 50, by 
“Tatchempharmpreparaty” JSC (Kazan, Russia), 
batch number 10218. According to Data Sheet 
No. 458, the drug content was 0.0092 g per 
tablet (tolerances of no less than 0.0085 g per 
tablet and no more than 0.0115 g per tablet, i.e. 
85-115%). The dose of Perphenazine in a 
pharmaceutical preparation, was 10 mg/tablet. 
Thus, ten tablets were powdered and a suitable 
quantity of the sample was accurately weighed 
and dissolved in 0.4 mol L-1 of hydrochloric 
acid solution. The solubility was increased by 
using an ultrasonic bath. 
Preparation of 0.0085 mol L-1 
diperoxyazelaic acid. Weigh 0.2 g of diperoxy 
azelaic acid powder and dissolve in 100 mL of 
50% ethanol. The content is determined by 
iodometric titration. 
The standard solution (0.1 mg ml-1) of 
perphenazine dihydrochloride (Sigma, St. Louis, 
Missouri, USA) was prepared by dissolving a 
weighed amount of the drug (containing 10.0 
mg of the Perphenazine base, С21Н26СlN3OS) in 
100.0 mL of 0.4 mol L-1 hydrochloric acid 
solution at +20°С. It was stored in a refrigerator 
and protected from light. 
All chemicals used were of the analytical 
reagent grade, and double-distilled water was 
used throughout the experiment. 
Apparatus 
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Registration of spectra of Perphenazine 
hydrochloride solutions and products of its 
oxidation, as well as measurement of 
absorbance of solutions, was performed in a 1 
cm quartz cuvette on an Evolution 60S UV-
Visible Thermo-Scientific Spectrophotometer 
(USA) against a solution without the 
Phenothiazine derivative analyzed or double-
distilled water (compensation solution). 
The рН of the solution was measured by 
the electrometric method using an “Ionmeter I-
130” potentiometer with an ESL-43-07 glass 
electrode. 
A 10 ml class 2 microburette was used to 
measure the volume of the titrant solution. 
Procedure  
Preparation of the calibration curve  
Using a pipette sample 2.00; 5.00; 10.00; 15.00 
and 20.00 mL of Perphenazine standard solution 
and transfer to 50 mL flasks, then sequentially 
add 10 mL of 2 mol L-1 hydrochloric acid 
solution and 1.0 mL of 0.0085 mol L-1 diperoxy 
azelaic acid solution to each flask, and dilute to 
the volume with double distilled water capped 
and thoroughly mixed by upturning the flask 7-
10 times. The absorbance was measured at 342 
nm using double distilled water as a 
compensation solution. 
Procedure for Pharmaceutical Preparation 
Determination of the Perphenazine content in 
Ethaperazine film-coated tablets, 10 mg. 
Powder 20 tablets and accurately weigh 
approximately 0.31 g of the sample and mix 
with 50 mL of 0.4 mol L-1 hydrochloric acid 
solution and thoroughly shake for 30 min, filter 
through a glass microfiber paper filter, rinse the 
residue carefully on the filter (3 times by 10 
mL) with the recommended solution, and once 
the filtrates are combined, transfer the solution 
to a 100 mL flask. Dilute the solution volumes 
with the recommended solvent and thoroughly 
stir up. Using a pipette sample 20 mL of the 
Perphenazine solution obtained and transfer to 
50 mL flasks, then sequentially add 10 mL of 2 
mol L-1 hydrochloric acid solution and 1.0 mL 
of 0.0085 mol L-1 diperoxy azelaic acid 
solution, and dilute to the volume with double 
distilled water capped and thoroughly mixed by 
upturning the flask 7-10 times. The absorbance 
was measured at 342 nm using double distilled 
water as a compensation solution. 
The similar procedure was performed with the 
standard solution (SS) according to instructions 
to the method starting with “…sample 20 mL of 
the Perphenazine solution obtained…”. 
 The content of Perphenazine 
dihydrochloride expressed as the Perphenazine 
base (С21Н26СlN3OS) (Х) per mg in the tablet is 
calculated according to the following formula: 
Х=(Cst×Ax×100× )/(A ×m) 
where Ах is the absorbance of the test solution; 
A is the absorption in the experiment with the 
SS; 
 Сst is the drug content in the SS, mg mL-1; 
m is the weighed mass of the tablet powder, g; 
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100 is the flask volume for pharmaceutical or 
standard solution preparation;   
 is the average mass of a tablet, g. 
Results and discussion 
Figure 4 shows the UV-spectrum of 
Perphenazine (lower curve) and its S-oxidation 
product – the corresponding sulfoxide (upper 
curve). 
Figure 4. The UV-spectrum of Perphenazine (lower 
curve) and its S-oxidation product – the corresponding 
sulfoxide (upper curve). С=40 µg mL-1, 0.4 mol L-1 НСl 
The linear dependence of the absorbance was 
observed in the concentration range of 1 to 40 
µg mL-1 of Perphenazine (А=0.0134±0.0006)С 
– (0.004±0.01), r=0.999) where С – the 
concentration in µg mL-1 (Figure 5 and 6). 
 
 
Figure 5. The concentration dependent UV-spectra of the 
S-oxidation product of Perphenazine (Perphenazine base), 
С, µg mL-1:1 – 4; 2 – 10; 3 – 20; 4 – 30; 5 – 40. 0.4 mol 
L-1 НСl 
At 342 nm, the molar absorptivity was 
5.45·103 L·mol-1·cm-1. LOD(3S) =0.6 µg mL-1; 
LOQ(10S)=1.9 µg mL-1. 
 
 
Figure 6. The dependence of absorption on the 
Perphenazine concentration 
Various quantities of interfering compounds that 
were possible during production were added to a 
fixed amount of perphenazine dihydrochloride 
(10 mg) studied, and the recommended 
procedure for the spectrophotometric 
determination was followed (Table 1). Other 
compounds, such as ascorbic acid, 
microcrystalline cellulose, polyethylene glycol 
and potassium hydrogen sulfite did not show 
any interference as well. 
 The data obtained showed a prospect of 
the possibility of using the method developed 
for the analysis of the tablet form of the drug. 
Table 2 shows the results of the analysis of 
Perphenazine in film-coated tablets (10 mg) 
obtained by the spectrophotometric method 
proposed. It has been proven that the method 
developed allows accurately determining 
Perphenazine in a dosage form. 
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Table 1. The quantitative assessment of tolerable amounts 
of the possible interference 
Possible interfering Inactive 
Excipients of the drug 
The 
amount 
without 
interferinga 
(mg) 
Excipients : 
 
Lactose monohydrate 
 
Potato starch 
 
Corn starch 
 
Calcium stearate  
 
Magnesium stearate 
 
 
 
125.0  
 
13.5 
 
13.5 
 
1.5 
 
1.5 
Shell Excipients: 
Sucrose  
Magnesium hydroxy  
carbonate 
Povidone 
Colloidal silicon dioxide 
Tropeolin O 
Yellow quinoline 
Indigo carmine 
Titanium dioxide 
Bee wax 
 
93 
 
50 
2 
3.3 
0.01 
0.13 
0.01 
1.5 
0.22 
 
a The value is mg of the drug excipient with 
respect to 10 mg of perphenazine, which does 
not cause absorption changes by more than 
+0.005. 
 
The RSD does not exceed ± 2 %. The 
results are in good agreement with the analysis 
of Perphenazine tablets according to the 
Specification. The determination of 
Perphenazine in the form of the corresponding 
sulfoxide obtained with the use of 
diperoxyazelaic acid as an analytical reagent is 
quite selective, as well as faster and less 
laborious and cheaper compared to the methods 
based on the formation of phenothiazine free 
radicals [3] or the complex with Palladium salt 
[16], respectively. The official method of 
analysis of Perphenazine tablets recommended 
by the British Pharmacopoeia (BPh), in our 
opinion, is also relatively difficult to implement 
and takes a lot of time. 
Table 2. The results of the assay for Perphenazine film-
coated tablets, 10 mg 
Taken Found Metrological 
characteristics 
mg per 
tablet 
Р=0.95 
0.33701 g (9.2 mg 
Perphenazine per 
tablet ± 10%) 
“ETAPERAZINE” 
“Tatchempharm-
preparaty” JSC 
(Kazan, Russia) 
8.90 
9.15 
9.35 
9.25 
9.28 
9.00 
8.92 
x  = 9.12 
S = 0.18 
S
x
 = 0.07 
x  = 0.17 
RSD = 2.00 
% 
δ* = – 0.85 % 
Notes: * The calculation is made using the µ 
analysis specification data, δ = ( x -µ) 100%/µ  
Conclusions 
On the example of the determination of 
Perphenazine in a dosage form using 
diperoxyazelaic acid as an oxidizing agent the 
method for the indirect spectrophotometric 
determination of phenothiazine derivatives with 
piperazine rings in side chains in ition 10 has 
been proposed. The linear dependence of the 
absorbance was observed in the concentration 
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range of 40 µg mL-1 of Perphenazine (А=0.0134 
С, r=0.999) where С – the concentration in µg 
mL-1. At 342 nm, the molar absorptivity was 
5.45·103 L·mol-1·cm-1. LOD(3S) =1.1 µg mL-1; 
LOQ(10S)=3.3 µg mL-1. The assay of 
Perphenazine in the form of the corresponding 
sulfoxide obtained with the use of 
diperoxyazelaic acid as an analytical reagent is 
quite selective, as well as faster and less 
laborious and cheaper compared to methods 
based on the formation of phenothiazine free 
cation-radicals or the complex with Palladium 
salt, respectively. 
References 
[1] Hartung B, Sampson S, Leucht S, Hartung B, 
Sampson S, Leucht S. Cochrane Database of 
Systematic Reviews Perphenazine for schizophrenia 
(Review). Perphenazine for schizophrenia. Cochrane 
Database of Systematic Reviews 2015;3:1-447. Art. 
No.: CD003443. Published by John Wiley & Sons, 
Ltd. DOI: 10.1002/14651858. CD003443.pub3 
[2] Puzanowska-Tarasiewicz H, Kuźmicka L, Karpińska 
J, Mielech-Lukasiewicz K. Efficient oxidizing agents 
for determination of 2,10-disubstituted 
phenothiazines. Anal. Sci. 2005; 21(10): 1149-1153. 
DOI: 10.2116/analsci.21.1149 
[3] Wang, R.-Y., & Lu, Y.-T. Kinetic spectrophotometric 
method for determination of perphenazine based on 
monitoring the oxidation intermediate by applying a 
stopped-flow technique. Spectrochimica Acta Part A: 
Molecular and Biomolecular Spectroscopy. 2005,  
61(5), 791–797. doi:10.1016/j.saa.2004.05.026   
[4] Ling Wang, Yan-Yu Xiao, Ming-Lei Chen, Fan Zeng, 
Li Zong. Pharmacokinetics of orally disintegrating 
tablets of perphenazine/hydroxypropyl-cyclodextrin 
inclusion complex in rabbits. Pharmazie 2013; 
68(10):800–804. DOI: 10.1691/ph.2013.2244 
[5] Saar E, Gerostamoulos D, Drummer OH, Beyer J. 
Identification and quantification of 30 antipsychotics 
in blood using LC-MS/MS. J. Mass Spectrom 2010, 
45(8):915–925. DOI: 10.1002/jms.1783. 
[6] Turunen E, Lehtonen M, Järvinen T, Jarho P. 
Development and validation of a gas 
chromatographic-mass spectrometric method for 
quantitative determination of perphenazine in rabbit 
plasma after sublingual administration. J Chromatogr 
B Analyt Technol Biomed Life Sci 2008, 872(1-2):51-
57. DOI:10.1016/j.jchromb.2008.07.010 
[7] Patel, D., & Patel, V. Simultaneous estimation of 
Amitriptyline Hydrochloride and Perphenazine by 
Absorption Ratio (Q-analysis) UV Spectrophotometric 
method in combined tablet dosage form. Int J Pharm 
Sci Res, 2010; 1: 133-137. DOI: 
http://dx.doi.org/10.13040/IJPSR.0975-
8232.1(12).133-37 
[8] Li Guo, Yan Zhang, Quanmin Li. Spectrophotometric 
determination of perphenazine with the detection 
system of potassium ferricyanide–Fe(III) in 
pharmaceutical and serum samples. Spectrochimica 
Acta Part A: Molecular and Biomolecular 
Spectroscopy 2009, 74(2):307-311. 
https://doi.org/10.1016/j.saa.2009.06.012 
[9] Heli H, Sattarahmady N, Zare SN. Electrooxidation 
and determination of perphenazine on a graphene 
oxide nanosheet-modified electrode. RSC Advances 
2015, 27:21005-21011. DOI:10.1039/C5RA01405K 
[10] Fasihi F, Farjami F, Shafiee GH. Highly 
sensitive determination of perphenazine on a carbon 
nanocomposite ionic liquid electrode. RSC Advances 
2015, 115:95087-95095. doi: 10.1039/C5RA14639A 
[11] Cosofret Vasile V. Pharmaceutical Applications 
of Membrane Sensors/ by Vasile V. Cosofret and 
Richard P. Buck. CRC Press, 2018:443. ISBN 
9781351075497 - CAT# KE61215 
[12] Tu YY. Hsieh MM, Chang SY. Sensitive 
detection of piperazinyl phenothiazine drugs by field-
amplified sample stacking in capillary electrophoresis 
FRENCH-UKRAINIAN JOURNAL OF CHEMISTRY (2019, VOLUME 07, ISSUE 02)  
103 
 
with dispersive liquid–liquid microextraction. 
Electrophoresis 2015, 36(21-22):2828-2836. 
doi:10.1002/elps.201500260. 
[13] Stolman A. Progress in Chemical Toxicology 
Vol. 5 / Ed. Abraham Stolman. Elsevier, 2013:406. 
ISBN: 9781483219233 
[14] Rezaei B, Mokhtari A. Sensitive determination 
of perphenazine in pharmaceuticals and human serum 
by flow injection chemiluminescence method using 
[Ru(phen)3]2+-Ce(IV) system and a chemometrical 
optimization approach. J. Braz. Chem. Soc. 2011, 
22(1) http://dx.doi.org/10.1590/S0103-
50532011000100006 
[15] The British Pharmacopoeia Commission 
Secretariat of the Medicines and Healthcare Products 
Regulatory Agency (MHRA) The British 
Pharmacopoeia 2019. London, United Kingdom: TSO 
(The Stationery Office); 1 January 2019; Available 
from 
https://www.tsoshop.co.uk/Medical/MHRA/British-
Pharmacopoeia-2019/ 
[16] The United States Pharmacopeia, Thirty-Ninth 
Revision, and The National Formulary, Thirty-Fourth 
Edition. The United States Pharmacopeial Convention 
12601 Twinbrook Parkway, Rockville, MD 20852 
[17] Shlusar, O. E., & Blazheevski, M. Y.. 
Spectrophotometric determination of perphenazine as 
it’s sulphoxide obtained by peroxomonosulphate. 
Farmatsevtychnyi Zhurnal, 2012; 4: 71-75 
(Ukrainian). Retrieved from 
https://pharmj.org.ua/index.php/journal/article/view/5
01  
[18] Blazheyevskiy M.Ye. Application of 
derivatization by means of peroxy acid oxidation and 
perhydrolysis reactions in pharmaceutical analysis : 
Monograph – Lviv: Ivan Franko National University 
of Lviv, 2017:106. 
